1. Home
  2. EEX vs AMPH Comparison

EEX vs AMPH Comparison

Compare EEX & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Emerald Holding Inc.

EEX

Emerald Holding Inc.

HOLD

Current Price

$4.99

Market Cap

890.6M

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.78

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEX
AMPH
Founded
2013
1996
Country
United States
United States
Employees
821
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
890.6M
971.8M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
EEX
AMPH
Price
$4.99
$18.78
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$7.70
$28.38
AVG Volume (30 Days)
714.2K
710.6K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
1.27%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
$7.49
$6.90
Revenue Next Year
$6.81
$4.64
P/E Ratio
$236.96
$137.93
Revenue Growth
N/A
N/A
52 Week Low
$3.32
$16.65
52 Week High
$5.45
$31.26

Technical Indicators

Market Signals
Indicator
EEX
AMPH
Relative Strength Index (RSI) 57.33 44.87
Support Level $4.81 $16.84
Resistance Level $5.09 $20.08
Average True Range (ATR) 0.03 0.80
MACD -0.01 0.11
Stochastic Oscillator 13.65 73.53

Price Performance

Historical Comparison
EEX
AMPH

About EEX Emerald Holding Inc.

Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States, with operations in the United Kingdom (U.K.), France, and other markets. The company is engaged in three complementary business lines: Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division provides B2B e-commerce and digital merchandising solutions to manufacturers and retailers. Emerald's key revenue is derived from the Connections business, its only reportable segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: